A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects

Clinical trial NCT05846009 · COMPLETED

Trial details

NCT number: NCT05846009
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteochondrodysplasia

Start date: 2020-11-18
Primary completion: 2022-01-12
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.